Skip to main content
FinSpry Logo
FinSpry
CBIO logo
CBIO
(NASDAQ)
Crescent Biopharma, Inc.
$20.46-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Crescent Biopharma (CBIO) Stock Price & Financial Analysis

Crescent Biopharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$19.91 - $21.19
52-Week High$27.41
52-Week Low$8.72
Open$20.58
Volume646.53K
Average Volume (3M)255.83K
Market Cap637.51M
Shares Outstanding30.53M
Price to Sales (P/S)53.65
Price to Book (P/B)4.00
EV/EBITDA-2.82
Revenue (TTM)11.88M
Net Income (TTM)-165.12M
Free Cash Flow (TTM)-153.62M
EPS (TTM)$-6.76
Profit Margin-1389.58%
Operating Margin-1417.74%
Return on Equity (ROE)-103.70%
Debt to Equity0.01
50-Day MA$16.84
200-Day MA$15.50
52-Week Change57.99%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateJan 13, 2023

Frequently Asked Questions About Crescent Biopharma

What is the current stock price for CBIO?

As of the latest trading session, CBIO stock trades at $20.46. The 52-week range is $8.72–$27.41, with a day range of $19.91–$21.19.

What is the P/E ratio for CBIO?

The P/E ratio (Price-to-Earnings) for CBIO is shown in the Key Statistics section. This valuation metric helps compare Crescent Biopharma, Inc. to industry peers.

Does CBIO pay dividends?

Crescent Biopharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CBIO?

Based on 2 analysts, the consensus for CBIO is Buy.

What is the market cap of CBIO?

Crescent Biopharma's market capitalization is $624.7M, classifying it as a small-cap company. Crescent Biopharma operates in the Healthcare sector within the Biotechnology industry.